Background: After hepatitis C virus (HCV) cure, there remains a substantial risk of developing hepatocellular carcinoma (HCC) in cirrhotic patients. As screening and early detection greatly improves HCC prognosis, it is important to understand factors influencing adherence to post sustained virologic response (SVR) care to maximize the impact of curative therapy. Aims: We evaluated adherence to HCC screening at 6-month intervals in a cohort of cirrhotic patients cured of HCV. Methods: Using a retrospective cohort study design, all cirrhotic patients achieving SVR enrolled in the Hepatitis C positive and At-Risk (HEAR) database from April 2014 to April 2016 were extracted for analysis. Health records were reviewed for liver imaging during 6-month intervals post-SVR up to February 28, 2018. Patients were categorized as (1) receiving all follow-up at 6-month intervals, and (2) receiving at least 1 liver image during follow-up. Univariate and multivariate odds ratios were calculated for variables which may impact HCC surveillance. Results: 49 cirrhotic patients were included with a mean follow-up time of 845.6 days (range 219-1043). Four patients (10.6%) had appropriate HCC surveillance at all 6month intervals while 57.1% (n=28) had at least 1 liver image performed.
There is a need for comprehensive strategies to ensure ongoing safety of HCV patients across the entire cascade of care, including after HCV cure.
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